Cannabis Archives - Page 422 of 449

2 minute read

What’s Going On With MindMed? Co-Founder Dr. Scott Freeman Lays Out ‘Value Enhancement Plan’

August 11, 12:47 PM

FCM MM Holdings sent a letter to MindMed’s (NASDAQ: MNMD) board of directors calling on them to adopt a new strategic plan to "turn the company around.”

MNMD

2 minute read

The Now Corp. Acquires An Equity Stake In Social Media Company

By Vuk Zdinjak

August 11, 11:54 AM

The Now Corporation (OTCPK:NWPN) has acquired a 28% equity stake in MePeeps Inc.

NWPN

1 minute read

Video: Why Heineken Beer Smells Like Weed And Other Thruths About Terpenes

By Javier Hasse

August 11, 11:51 AM

Do you know what terpenes are and what they do? Have you ever wondered why Heineken beer (OTC: HEINY) smell like weed? Check out this interview with Max Koby, CEO of Abstrax Tech.

HEINY

5 minute read

Top Cannabis Regulator Jumps To Another Gig, Bhang CEO Steps Down & Other Strategic Marijuana Industry Leadership Changes

By Nina Zdinjak

August 11, 10:44 AM

As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.

BHNGF

2 minute read

Zoned Properties Q2 Revenue Declines 9.3%, But Still Up 60% Over 6-Month Period: Here Are The Details

By Vuk Zdinjak

August 11, 10:38 AM

Zoned Properties, Inc. (OTCQB: ZDPY) Q2 2022 revenue was $498,652, a decrease of 9.3% compared to $550,064 in Q2 2021. Q2 2022 Financial Highlights

ZDPY

1 minute read

Christina Lake Cannabis Q2 Revenue Shows Strong Growth Both Sequentially And YoY, Here Are The Details

By Vuk Zdinjak

August 11, 9:27 AM

Christina Lake Cannabis Corp. (OTCQB: CLCFF) (CSE:CLC) revenue in Q2 2022 was CA$2.3 million ($1.8 million), a 40% increase over Q1

CLCFF

1 minute read

Cantor Fitzgerald Maintains Overweight on Trulieve Cannabis, Lowers Price Target to $54

By Benzinga Newsdesk

August 11, 5:15 AM

Cantor Fitzgerald analyst Pablo Zuanic maintains Trulieve Cannabis (OTC:TCNNF) with a Overweight and lowers the price target from $57 to $54.

TCNNF

3 minute read

Trulieve Cannabis: A Top Pick Operator In A Small Pond? Analyst Offers Model Update Post 2Q22

By Nicolas Jose Rodriguez

August 10, 6:07 PM

The Analyst Pablo Zuanic from Cantor Fitzgerald maintained a rating of Overweight for the stocks of Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) and lowered its price target to $54 from $57, on “slightly reduced estimates.”

ACRDF